_×
  0 products, total $0.+86-400-890-9989      Login |  Register 中文한국어

Browse By Molecule:

Your Position: Home > CD137 Protein (4-1BB, TNFRSF9 Protein)

CD137 Protein (4-1BB, TNFRSF9 Protein)

Cluster of Differentiation 137 (Tumor Necrosis Factor Receptor Superfamily, member 9)

CD137 Products

CD137 Protein, Recombinant

Molecule Species Description //For Detailed Info. and Price------CLICK! Cat. No
CD137/4-1BB/TNFRSF9 Human CD137/4-1BB/TNFRSF9/Fc Protein, Recombinant 10041-H03H
CD137/4-1BB/TNFRSF9 Human CD137/4-1BB/TNFRSF9 Protein, Recombinant 10041-H08H
CD137/4-1BB/TNFRSF9 Mouse CD137/4-1BB/TNFRSF9 Protein, Recombinant 50811-M02H

  10041-H03H:  Immobilized recombinant mouse 4-1BB Ligand at 20 µg/ml (100 µl/well) can bind human 4-1BB with a linear range of 15.6-500 ng/ml. Measured by its binding ability in a functional ELISA.

CD137 Antibody

Molecule Application Description //For Detailed Info. and Price------CLICK! Cat. No
Human
CD137/4-1BB/TNFRSF9
WB, ELISA Rabbit Polyclonal Antibody (Antigen Affinity Purified) 10041-RP02

CD137 cDNA Clone

Molecule Species Description //For Detailed Info. and Price------CLICK! Cat. No
CD137/4-1BB/TNFRSF9 Human Homo sapiens CD137/4-1BB/TNFRSF9 cDNA Clone(NM_001561.4) HG10041-M
CD137/4-1BB/TNFRSF9 Human Human CD137 / 4-1BB / TNFRSF9 ORF Expression Clone, HA-tagged HG10041-M-Y
CD137/4-1BB/TNFRSF9 Mouse Mouse CD137/4-1BB/TNFRSF9 cDNA Clone / ORF Clone MG50811-G
CD137/4-1BB/TNFRSF9 Canine Canine TNFRSF9 Gene cDNA Clone / ORF Clone DG70095-G
CD137/4-1BB/TNFRSF9 Rat Rat CD137/4-1BB/TNFRSF9 cDNA Clone / ORF Clone RG80176-G

CD137 Related Areas

Immunology>>Adaptive Immunity>>Costimulation & Costimulatory Molecule>>CD137/4-1BB/TNFRSF9

Immunology>>Cytokine & Receptor>>TNF Superfamily>>CD137/4-1BB/TNFRSF9

Immunology>>Cluster of Differentiation>>Dendritic Cell CD Antigen>>Dendritic Cell Co-stimulatory Molecules>>CD137/4-1BB/TNFRSF9

Immunology>>Cluster of Differentiation>>Monocyte/Macrophage CD Antigen>>Other>>CD137/4-1BB/TNFRSF9

Immunology>>Cluster of Differentiation>>Natural Killer (NK) Cell CD Antigen>>CD137/4-1BB/TNFRSF9

Immunology>>Cluster of Differentiation>>T Cell CD Antigen>>Helper T Cells>>CD137/4-1BB/TNFRSF9

CD137 Alternative Names

CD137, 4-1BB, TNFRSF9, CDw137, ILA, MGC2172 [Homo sapiens]

Cd137, 4-1BB, Tnfrsf9, CDw137, ILA, RP23-272N19.6, A930040I11Rik, AA408498, AI325004, Ly63 [Mus musculus]

CD137 Background

CD137 (also known as 4-1BB) is a surface co-stimulatory glycoprotein originally described as present on activated T lymphocytes, which belongs to the tumor necrosis factor (TNF) receptor superfamily. It is expressed mainly on activated CD4+ and CD8+ T cells, and binds to a high-affinity ligand (4-1BBL) expressed on several antigen-presenting cells such as macrophages and activated B cells. Upon ligand binding, 4-1BB is associated with the tumor necrosis factor receptor–associated factors (TRAFs), the adaptor protein which mediates downstream signaling events including the activation of NF-kappaB and cytokine production. 4-1BB signaling either by binding to 4-1BBL or by antibody ligation delivers signals for T-cell activation and growth, as well as monocyte proliferation and B-cell survival, and plays an important role in the amplification of T cell-mediated immune responses. In addition, CD137 and CD137L are expressed in different human primary tumor tissues, suggesting that they may influence the progression of tumors. Crosslinking of CD137 on activated T cells has shown promise in enhancing anti-tumor immune responses in murine models, and agonistic anti-CD137 antibodies are currently being tested in phase I clinical trials.

CD137 Related Studies

  1. Sica G, et al. (1999) Biochemical and immunological characteristics of 4-1BB (CD137) receptor and ligand and potential applications in cancer therapy. Arch Immunol Ther Exp (Warsz). 47(5): 275-9.
  2. Nam KO, et al. (2005) The therapeutic potential of 4-1BB (CD137) in cancer. Curr Cancer Drug Targets. 5(5): 357-63.
  3. Wang Q, et al. (2008) Analysis of CD137 and CD137L expression in human primary tumor tissues. Croat Med J. 49(2): 192-200.
  4. Melero I, et al. (2008) Multi-layered action mechanisms of CD137 (4-1BB)-targeted immunotherapies. Trends Pharmacol Sci. 29(8): 383-90.
  5. Thum E, et al. (2009) CD137, implications in immunity and potential for therapy. Front Biosci. 14: 4173-88.
 

 

 

 

 

 

CD137/4-1BB related areas, pathways, and other information

TNF Superfamily Ligands

  • EDA-A1 / Ectodysplasin-A1*
  • TNFSF6 / CD95L / CD178*
  • TNFSF12 / TWEAK*
  • TNFSF13 / CD256*
  • TNFSF3 / TNFC / lymphotoxin beta*
  • TNFSF4*
  • TNFSF15*

TNF Receptor Superfamily

  • TNFRSF3 / CD18 / LTBR*
  • TNFRSF10C / CD263 / TRAILR3*
  • TNFRSF18*
  • TNFRSF12A / FN14 / TWEAKR*